Drugs / Buprenorphine/naloxone
last change Jan 1997 re-read 3 minutes ago

Buprenorphine/naloxone

Developed for
opiate dependence
Investigated by
Cincinnati MDRU · National Institute on Drug Abuse (NIDA)

Trials 1

19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00015028 Nov → Dec 1996 opiate dependence National Institute on Drug Abuse (NIDA) Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Buprenorphine/naloxone ClinicalTrials.gov intervention name — accepted as the source's own label NCT00015028 ↗